Accel-KKR have made a strategic equity investment in IntegriChain. Terms of the deal call for Accel-KKR to buy all of IntegriChain. Financial terms weren’t announced. Philadelphia-based IntegriChain is a cloud software company focused on channel management for life sciences suppliers.
CORRECTION: A prior version of this story incorrectly said that Accel-KKR was buying 10 percent of IntegriChain. Accel-KKR is buying all of the company. The story has been corrected.
PHILADELPHIA, March 1, 2016 /PRNewswire/ — IntegriChain, a rapidly growing cloud software company focused on channel management for life sciences suppliers, today announced that it has received a strategic equity investment from Accel-KKR, a leading technology-focused private equity firm. Under the terms of the investment, Accel-KKR will acquire 100% of the equity not held by members of IntegriChain’s management team.
“With its focus on vertically oriented businesses, Accel-KKR is the ideal partner for IntegriChain, and together we will help life sciences companies maximize patient access to life-improving products,” said Kevin Leininger, co-founder and Chief Executive Officer of IntegriChain. “This partnership validates our growth strategy and will enable us to extend our leadership in delivering solutions that improve life sciences suppliers’ management of their channel relationships, inventories, and orders across a vast network of retailers, ecommerce, and distributors.”
“IntegriChain has built a reputation as an innovator and a company that provides a high level of customer service,” said co-founder and Executive Vice President Josh Halpern. “We believe that our partnership with Accel-KKR will benefit both our customers as we continue to innovate and our employees as we continue to grow and thrive.”
“With its industry-leading cloud platform, superior service, and a rapidly growing customer base of top-tier life sciences manufacturers, IntegriChain is a model Accel-KKR investment,” said Fred Sturgis, Managing Director at Accel-KKR. “We look forward to working with the IntegriChain team as they continue to grow and drive innovation in the life sciences channel.”
Needham & Company served as the exclusive financial advisor to IntegriChain on this transaction.
IntegriChain is the leading channel management cloud used by life sciences suppliers, including nine of the top 10 pharmaceutical manufacturers, to drive channel collaboration and to improve the efficiency of how products reach customers. Pharmaceutical, biopharm/specialty pharma, generics, and consumer health suppliers use IntegriChain to manage their supply chain relationships, inventories, and orders across a vast network of retailers, ecommerce, and distributors. As a suite of informed applications and analytics built on top of aggregated channel inventory and point-of-sale (POS) data, IntegriChain provides customer operations, national accounts, and finance teams with a collaborative, agile, and mobile alternative to ERP and homegrown systems. By embedding big-data customer insights into daily business processes, IntegriChain helps control the high cost of product distribution while improving product availability, ensuring a higher level of revenue predictability and maximizing distribution investment. More than$200 billion in annual U.S. commerce and 2 billion transactions flow through the IntegriChain Cloud annually. IntegriChain is backed by Accel-KKR, a leading technology private equity firm. For more information, visit www.integrichain.com and follow us on Twitter @IntegriChain and LinkedIn.
Accel-KKR is a technology-focused investment firm with $4.0 billion in capital commitments to its current funds. The firm invests in software and IT enabled businesses well-positioned for topline and bottom-line growth. At the core of Accel-KKR’s investment strategy is a commitment to developing strong partnerships with the management teams of its portfolio companies and a focus on building value through significant resources available through the Accel-KKR network. Accel-KKR focuses on middle-market companies and provides a broad range of capital solutions from minority-growth investments to buyouts, recapitalizations, divisional carve-outs and going-private transactions. The firm has offices in Menlo Park, Atlanta and London. For more information, please visit www.accel-kkr.com.
IntegriChain is a registered trademark of IntegriChain Incorporated. All other trademarks are property of their respective owners.